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Abstract
Most cases of lung cancer have a commonly-understood behavioral etiology. Thus,
individuals with lung cancer are often blamed for their illness by others and may
therefore seek to avoid this blame by concealing their diagnosis from others. This study
sought to determine the prevalence of diagnosis concealment, examine potential
predictors of concealment, and test parts of a cognitive-affective-behavioral model of the
effects of concealing a concealable stigma among individuals receiving treatment for
lung cancer. With regard to predictors of concealment, it was hypothesized that
concealment would be positively associated with male gender, introversion, and trait
social anxiety and would be negatively associated with social support and the use of
seeking guidance and support as a coping strategy. Hypothesized correlates of
concealment included poorer self-esteem as well as greater anxiety, cancer-specific
distress, and social avoidance. A sample of 117 participants receiving chemotherapy or
radiation for stage I-IV non-small cell lung cancer and limited to extensive stage small
cell lung cancer was recruited during routine outpatient visits. A medical chart review
was conducted to assess clinical factors and participants completed a standard
demographic questionnaire as well as measures of coping strategies, introversion, trait
social anxiety, social avoidance, social support, anxiety, depression, cancer-specific
distress, self-esteem, perceived stigma, public self-consciousness, and private selfconsciousness. Results indicated that 31% of participants concealed their diagnosis from
others since their diagnosis and 26% concealed their diagnosis in the month preceding
v

their participation in the study. Hypotheses regarding predictors and correlates of
concealment were not supported. However, exploratory analyses identified use of
alcohol, recency of a recurrence of lung cancer, use of positive reappraisal as a coping
strategy, and social support as predictors of concealment as well as internalized shame as
a correlate of concealment. These findings serve to extend existing literature on
concealing a concealable stigma and support parts of an existing model on the effects of
concealment. Future research should aim to test the impacts of concealment in the context
of certain social situations to examine longitudinal relationships between predictors and
consequences of concealment.
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Introduction
Estimates suggest that in 2010 over 220,000 Americans were diagnosed with lung
cancer and over 150,000 died of this disease (Jemal, Siegel, Xu, & Ward, 2010). Unlike
many other forms of cancer, lung cancer is associated with a behavioral etiology (i.e.,
tobacco use). Accordingly, individuals with lung cancer may want to conceal their illness
due to the potential for stigmatization (Chapple, Ziebland, & McPherson, 2004; Holland,
Kelly, & Weinberger, 2010; Schonfeld & Timsit, 2008). Surprisingly, the extent to which
patients conceal a disease such as lung cancer remains largely unstudied. The current
study sought to evaluate the prevalence and predictors of diagnosis concealment and
determine whether diagnosis concealment is associated with negative affective,
behavioral, and self-evaluative implications in a sample of patients diagnosed with lung
cancer.
As noted above, lung cancer has a well-established behavioral etiology. Along
these lines, a recent study asked a sample of British women to rate the degree to which
they believed patients with various cancers were to blame for their illnesses. Seventy
percent considered lung cancer patients at least partly to blame for their illness, compared
to 9% for leukemia patients and 15% for breast cancer patients (Marlow, Waller, &
Wardle, 2010). Moreover, a study comparing attributions of blame found that lung cancer
patients blamed themselves for their diagnosis more than their primary caregivers did
(Lobchuk, Murdoch, McClement, & McPherson, 2008). Thus, individuals with lung
cancer can be considered at higher risk of stigmatization than individuals with many
1

other forms of cancer due to perceptions of blame. Moreover, some studies have shown
that illness-related perceived stigma is associated with poorer psychosocial well-being.
For example, in a recent study of lung cancer patients, perceived stigma was associated
with poorer social support and dyadic adjustment as well as increased depressive
symptomatology (Gonzalez & Jacobsen, 2011).
Although the motivation to conceal one’s lung cancer diagnosis is understandable,
no published quantitative studies could be found which examined diagnosis concealment
among individuals with cancer. Most studies of concealment in this population examine
the ethical issues regarding a physician disclosing a diagnosis to the patient. Only one
qualitative study could be found which discussed patients’ concealing their cancer
diagnoses from others. Donovan & Flynn (2007) interviewed men diagnosed with breast
cancer and found that concealing one’s diagnosis was one of four major themes
discussed. The rate, predictors, and correlates of concealment among men with this
stigmatizing diagnosis were not examined (Donovan & Flynn, 2007). To better
understand this phenomenon, I developed and pilot-tested a brief questionnaire designed
to assess whether or not individuals with a potentially stigmatizing diagnosis have chosen
to conceal their illness. Twenty participants in a previous study of lung cancer patients
were sampled. Seven (35%) reported that they had chosen to conceal their diagnosis from
family, people at work, or friends around the time their treatment began. In addition, five
(25%) reported that they were currently concealing their diagnosis from someone.
A review of the literature identified no quantitative studies of the predictors of
diagnosis concealment in people with cancer. In the absence of such research it may be
instructive to examine qualitative research on this topic in cancer populations and
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quantitative research in other populations. For example, several qualitative studies have
suggested that men with cancer are particularly resistant to discussing or disclosing their
diagnosis (Boehmer & Clark, 2001; Hilton, Emslie, Hunt, Chapple, & Ziebland, 2009;
Maliski, Rivera, Connor, Lopez, & Litwin, 2008). In a study about deciding whether or
not to disclose one’s cancer diagnosis, men were more likely than women to conceal their
diagnosis, citing gender expectations of them as being stoical men (Hilton et al., 2009).
Another study about men’s experiences with prostate cancer found that men cited the
need to protect others as a rationale for their reticence to discuss their diagnosis and their
feelings about its symptoms (Maliski et al., 2008). Other evidence suggests that greater
introversion and trait social anxiety is associated with greater tendencies to conceal
personal characteristics likely to be perceived as negative (Cepeda-Benito & Short, 1998;
Cramer & Lake, 1998; Wismeijer & van Assen, 2008). Along these lines, a study among
college students indicated that social anxiety was associated with greater general selfconcealment (i.e., the tendency to actively conceal from others) (Endler, Flett,
Macrodimitris, Corace, & Kocovski, 2002). In contrast, greater social support may have
the opposite effect. For example, among individuals with HIV, those who reported
greater social support were less likely to indicate that they had concealed their diagnosis
(Petrak, Doyle, Smith, Skinner, & Hedge, 2001). Use of certain coping strategies has also
been associated with concealment. In a qualitative study, Seale & Charteris-Black (2008)
interviewed individuals with various types of cancer. When deciding whether or not to
conceal their diagnosis from others, women were more concerned with maintaining their
social networks than men, suggesting that the coping strategy of seeking social support
may be associated with concealment (Seale & Charteris-Black, 2008). Similarly, a study

3

of individuals with HIV found that among those who disclosed their diagnosis the desire
for support was the most often endorsed reason for disclosure (Petrak et al., 2001).
Together, the results of these studies provide support for investigating associations
between concealment and gender, introversion, social anxiety, social support, and seeking
social support in lung cancer patients. Additionally, the literature on impression
management has also examined the concepts of public and private self-consciousness, the
tendencies to be concerned about aspects of the self that are easily observable or covert,
respectively (Leary, 1996). Although these concepts have not been examined as
predictors of concealment, they merit consideration because of their potential influence
on individuals’ decisions to conceal.
No published quantitative studies of the effects of concealing one’s cancer
diagnosis could be found, and only limited research has been conducted on this topic
among individuals with other illnesses. However, a model examining the potential effects
of concealing a concealable and potentially stigmatizing condition is of particular
importance (Pachankis, 2007; see Figure 1). The following is a brief description of the
most salient aspects of the model as it might relate to concealing a diagnosis of lung
cancer.
Pachankis (2007) posits that concealment of a potentially stigmatizing condition
can have negative affective, self-evaluative, and behavioral implications. Individuals who
choose to conceal such a condition must often make this decision multiple times, even in
one day, during encounters with family members, friends, and co-workers. Among those
who decide to conceal their condition, these repeated reminders of one’s condition may
lead them to suppress thoughts of their condition (Lane & Wegner, 1995). This thought
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suppression may place those who conceal their condition at elevated risk of depression,
anxiety, and distress (Brewin, Watson, McCarthy, Hyman, & Dayson, 1998; Purdon,
1999). Moreover, these potential affective responses can result in diminished self-esteem
among these individuals. In addition, individuals who conceal their potentially
stigmatizing condition may also isolate themselves and avoid others in order to avoid
these unpleasant consequences of associating with others.
Although a review of the literature identified no studies that have tested
hypotheses based on Pachankis’ (2007) model among cancer patients, several studies in
other populations are instructive. For example, in one study college students who
reported characteristics that might be considered concealable and stigmatizing (e.g., low
socioeconomic status, bulimia nervosa, or homosexual sexual orientation) reported
greater anxiety and depression as well as lower self-esteem than students with potentially
stigmatizing characteristics that are not concealable (e.g., being overweight or having a
stutter) (Frable, Platt, & Hoey, 1998). Another study sampled pregnant women just
before they were to have an abortion and again two years later (Major & Gramzow,
1999). Results showed an association between secrecy regarding the abortion and
psychological distress two years after the abortion; additional findings demonstrated that
this association was mediated by intrusive thoughts as well as suppression of thoughts
about their abortion (Major & Gramzow, 1999). These findings support extending
research using Pachankis’ model to the study of the affective, behavioral, and selfevaluative correlates of concealment among individuals with lung cancer.
Refining theories of the effects of concealment among individuals with lung
cancer could help mental providers better attend to their patients’ quality of life and well-
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being. For example, thoracic oncologists may become better equipped to identify
psychological distress associated with concealment and to address these issues. In
addition, such research could inform new psychotherapeutic interventions targeting the
potential affective, behavioral, and self-evaluative effects of concealment.
The Current Study: Overview, Aims, and Hypotheses
This study examined the prevalence, predictors, and correlates of concealment of
one’s lung cancer diagnosis. Participants were individuals receiving chemotherapy and/or
radiotherapy for treatment for lung cancer, because they may be more likely to have been
diagnosed more recently than others who are not receiving treatment. Also, because of
frequent medical appointments, patients receiving treatment may be more likely to be
making a deliberate decision regarding whether or not to conceal their diagnosis from
others. Specific aims and hypotheses follow.
Specific Aim 1. To determine the prevalence of diagnosis concealment among
lung cancer patients.
Specific Aim 2. To evaluate potential predictors of concealment. Hypothesis set
1: It was hypothesized that diagnosis concealment would be positively associated with
male gender, introversion, and trait social anxiety. It was hypothesized that diagnosis
concealment would be negatively associated with social support and use of seeking
guidance and support as a coping strategy. Exploratory analyses: Exploratory analyses
were conducted to determine whether age, smoking history, marital status, perceived
stigma, public self-consciousness, and private self-consciousness would be associated
with concealment. Depending on the outcomes of these exploratory analyses, hierarchical
regression analyses were planned to determine if psychosocial variables (e.g., social
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support) predicted concealment over and above relevant demographic and clinical
variables.
Specific Aim 3. To evaluate potential affective, behavioral, and self-evaluative
correlates of concealment of one’s lung cancer diagnosis. Hypothesis set 2: It was
hypothesized that concealment of one’s lung cancer diagnosis would be positively
associated with anxiety, depression, cancer-specific distress (affective correlates), social
avoidance (behavioral correlate), and poorer self-esteem (self-evaluative correlate).
Exploratory analyses: Mediational analyses were planned to explore whether expected
associations between concealment and affective outcomes were mediated by behavioral
and self-evaluative factors.

7

Affective Implications
-Anxiety
-Depression
-Distress

Stigma-Relevant Situation
-Salience of stigma
-Threat of discovery
-Consequences of discovery

Behavioral Implication
-Social avoidance/isolation

Self-Evaluative Implications
-↓ self-esteem

Figure 1. Adapted from Pachankis’ (2007) cognitive-affective-behavioral model for psychological implications of concealing a
stigma.
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Method
Participants
Eligibility criteria for this study were: 1) receiving chemotherapy and/or
radiotherapy for treatment of non-small cell lung cancer (NSCLC) or small cell lung
cancer (SCLC), 2) no history of other cancers with the exception of non-melanoma skin
cancers, 3) ≥ 18 years of age, 4) able to read English, and 5) able to provide informed
consent.
Procedure
Two procedures were used to recruit participants for this study. For both
procedures, study eligibility was determined in consultation with members of the H. Lee
Moffitt Cancer Center Thoracic Oncology Program team. The first study procedure
involved approaching potential participants during routine outpatient visits and
explaining the study protocol. Those eligible and interested provided written informed
consent. Participants were given the option of completing the study measures during their
outpatient visit or taking them home and returning them in a self-addressed stamped
envelope provided by study staff.
Those potential participants who were not scheduled to have a routine outpatient
visit to the H. Lee Moffitt Cancer Center within the next 3 weeks after they were
identified were recruited via mail. They were mailed a packet containing a cover letter
that explained the nature of the study and indicated that they would be contacted via
telephone to discuss participation. The packet also included a card which participants
9

could return in order to decline participation in the study without any further contact, two
informed consent forms, the study questionnaire, and a pre-addressed postage-paid
envelope in which they could return the declination card or a signed consent and a
completed study questionnaire. After the packet was mailed, potential participants were
contacted by phone and the study protocol was explained. Those eligible and interested
were asked to sign the consent forms, complete the study questionnaire, and return one
signed consent form with the completed questionnaire in the provided self-addressed
stamped envelope. Participants were not compensated for their study participation.
Measures
Demographics and background information. Demographics and background
information were collected using a standardized self-report form. The variables assessed
included age, sex, race, ethnicity, education, income, marital status, living arrangements,
employment status, and menopausal status (for women). In addition, participants
completed a measure of their smoking history, which was used to classify participants as
never smokers, former smokers, or current smokers. As part of this assessment, those
who had smoked at least 100 cigarettes in their lifetime were asked whether or not they
currently smoke. Both former smokers and current smokers were asked to indicate how
many cigarettes per day they do or did smoke as well as how many years they smoked.
Also, current smokers were asked to indicate how many times they have tried to quit
smoking. Former smokers were asked to indicate how long ago they quit smoking.
Clinical information. The following clinical information was assessed via a
review of patients’ medical records: date of lung cancer diagnosis, disease stage, disease
type (small cell vs. non-small cell), previous lung cancer treatment, current lung cancer
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treatment, and ECOG performance status (a measure of overall well-being) (Oken et al.,
1982).
Diagnosis concealment. Diagnosis concealment was assessed with a brief selfreport measure that was designed and pilot-tested for this study. Respondents were asked
to indicate whether or not they had chosen to conceal their lung cancer diagnosis (yes/no)
from anyone within certain specified groups (i.e., family, friends, and coworkers) within
two time frames: 1) since their cancer diagnosis and 2) within the past month. Those who
indicated they had chosen to conceal their lung cancer diagnosis were asked to indicate
their reason(s) for concealing by choosing from a specified list of reasons derived from
pilot-testing of this questionnaire (e.g., “I didn’t want them to worry about me”). In
addition, participants were asked to report how much discomfort, on a scale from 0 (no
discomfort) to 4 (extreme discomfort), disclosing or not disclosing their lung cancer
diagnosis to others caused in the past month. Lastly, participants were asked to report
how many occasions in the past month they chose not to disclose their diagnosis.
Coping. Coping strategies was assessed using the Coping Responses Inventory
(CRI; (Moos, 1993; Moos, 1993), a 48-item Likert-type instrument which assesses
specific coping responses via eight subscales. Responses are coded from 0 (not at all) to
3 (fairly often). Four subscales assess approach coping styles: seeking guidance and
support, problem solving, logical analysis, and positive reappraisal (Moos, 1993). Four
subscales assess avoidant coping styles: seeking alternative rewards, emotional discharge,
cognitive avoidance, and acceptance or resignation (Moos, 1993). The eight individual
subscales of the CRI have been validated (Moos, 1993) and been shown to have adequate
internal consistency reliability (α range: .61 - .74) in a sample of ovarian cancer patients
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(Chan, Ng, Lee, Ngan, & Wong, 2003). In the present study, analyses focused on the
seeking guidance and support subscale which asks questions such as, “Did you talk with
a friend about the problem?” In the present study, this scale demonstrated poor internal
consistency reliability (α = .54).
Introversion. Introversion was assessed using the Extraversion-Introversion
subscale of the NEO–Five Factor Inventory (NEO-FFI; (Costa Jr & McCrae, 1992). This
subscale has 12 items rated on a 5-point Likert-type scale, ranging from 1 (strongly
disagree) to 5 (strongly agree). Sample items include “I like to have a lot of people
around me” and “I really enjoy talking to people.” The NEO-FFI has demonstrated
acceptable reliability and validity in the general population as well as in individuals with
cancer (Costa Jr & McCrae, 1992; Montgomery et al., 2009). In the present study, this
scale demonstrated adequate internal consistency reliability (α = .79).
Trait social anxiety and social avoidance. Trait social anxiety and social
avoidance were assessed using the Liebowitz Social Anxiety Scale (LSAS; (Liebowitz,
1987), a 24-item measure which asks respondents to rate the fear/anxiety they experience
during certain social situations (e.g., speaking up at a meeting) on a 4-point Likert-type
scale ranging from 0 (none) to 3 (severe). Respondents are then asked to indicate the
degree to which they would avoid these social interactions. These items are also coded on
a 4-point Likert-type scale ranging from 0 (never) to 3 (usually) scale. The trait social
anxiety and social avoidance subscales have demonstrated acceptable reliability and
validity (Heimberg et al., 1999; Liebowitz, 1987). The social anxiety (α = .92) and social
avoidance (α = .89) scales demonstrated adequate internal consistency reliabilities in the
present study.
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Social support. Social support was assessed using the ENRICHD Social Support
Instrument (ESSI; (Mitchell et al., 2003; Mitchell et al., 2003), a 5-item Likert-type
instrument designed to assess emotional support. Responses range from 1 (none of the
time) to 5 (all of the time). The ESSI has been shown to have acceptable reliability and
validity (Mitchell et al., 2003; Mitchell et al., 2003). Sample questions include “Is there
someone available to give you good advice about a problem?” and “Is there someone
available to you who shows you love and affection?” (Mitchell et al., 2003; Mitchell et
al., 2003). In the present study, this scale demonstrated adequate internal consistency
reliability (α = .92).
Anxiety and depression. Anxiety and depression were assessed using the
respective Anxiety and Depression scales of the Hospital Anxiety and Depression Scale
(HADS; (Zigmond & Snaith, 1983). The HADS asks respondents to indicate on a 4-point
scale (from most of the time to not at all) how often they feel certain ways (e.g., I feel
tense or “wound up”). The anxiety and depression scales have demonstrated acceptable
validity and reliability and have been used extensively in studies of patients with cancer
(Ibbotson, Maguire, Selby, Priestman, & Wallace, 1994; Jacobsen & Jim, 2008). Sample
reverse coded items include “I can sit at ease and feel relaxed” and “I still enjoy the
things I used to enjoy.” (Zigmond & Snaith, 1983). The anxiety (α = .66) and depression
(α = .57) scales demonstrated poor internal consistency reliabilities in the present study.
Cancer-specific distress. Cancer-specific distress was assessed using the
intrusion subscale of the Impact of Events Scale – Revised (IES-R; (Weiss & Marmar,
1997), a 22-item Likert-type scale in which respondents are asked to rate how distressing
each item is on a scale from 0 (not at all) to 4 (extremely). Sample intrusion subscale
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items include “Other things kept making me think about it” and “Pictures about it popped
into my head.” Respondents were instructed to rate items with regard to the diagnosis and
treatment of their lung cancer. This scale, which has demonstrated acceptable reliability
and validity, has been extensively used in the cancer population as a measure of cancerspecific distress (Floyd et al., 2011; Weiss & Marmar, 1997). In the present study, this
scale demonstrated adequate internal consistency reliability (α = .87).
Self-esteem. Self-esteem was assessed using the Rosenberg Self-Esteem Scale
(RSES; (Rosenberg, 1979), a 10-item Likert-type scale in which respondents indicate on
a 4-point scale the degree to which they agree with statements such as “I feel I do not
have much to be proud of” and “I certainly feel useless at times.” Responses are scored
on a scale of 0 (strongly disagree) to 3 (strongly agree). This scale has demonstrated
adequate reliability and validity and has been used with numerous populations, including
with individuals with cancer (Greenfield et al., 2010; Rosenberg, 1979). In the present
study, this scale demonstrated adequate internal consistency reliability (α = .88).
Perceived stigma. Perceived stigma was assessed using the Social Impact Scale
(SIS; (Fife & Wright, 2000; Fife & Wright, 2000)), a 24-item Likert-type scale which
measures the extent to which individuals with an illness believe they are experiencing
social rejection, financial insecurity, internalized shame, and social isolation as a result of
their illness. In addition to a total score, the measure yields subscale scores for the four
aspects of experienced stigma described above. These four subscales have been shown to
have strong internal consistency reliability (α range: .85 - .90), and though they are
related, their relatively low zero-order correlations with one another (r range: .28 – .66)
suggest that they assess divergent aspects of one’s illness-related stigma (Fife & Wright,
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2000). In the present study, the total perceived stigma scale (α = .92) and the four
subscales (αs = .69 - .87) demonstrated adequate internal consistency reliabilities.
Public and private self-consciousness. Public and private self-consciousness
were assessed using the respective subscales of the Self-Consciousness Scale – Revised
(SCS-R; (Scheier & Carver, 1985). Public self-consciousness refers to the tendency to be
concerned about easily observable aspects of oneself, and private self-consciousness
refers to the tendency to be concerned about covert aspects of oneself that are not easily
observable. The 8- and 7-item subscales provide statements and ask respondents to rate
each on a 4-point Likert-type scale ranging from 0 (not like me at all) to 3 (a lot like me).
These scales have demonstrated adequate reliability and validity in previous studies
(Scheier & Carver, 1985). The public self-consciousness (α = .61) and private selfconsciousness (α = .64) subscales demonstrated slightly less than adequate internal
consistency reliabilities in the present study.
Statistical Analyses
Preliminary analyses. The rate of participation was computed, and those who
declined to participate were compared to those who participated to determine whether
demographic or clinical differences existed between these two groups. Descriptive
statistics (e.g., means and standard deviations) were computed to characterize the sample
in terms of its demographic, clinical, and psychological characteristics. In addition, the
prevalence of concealment was computed. Along these lines, the number of participants
who concealed their diagnosis from anyone was computed for both time frames (past
month and since cancer diagnosis), as well as a summary indicating from whom
participants chose to conceal their diagnosis and why.
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Hypothesis testing. Diagnosis concealment was dichotomized to compare
individuals who did not conceal their diagnosis from anyone in the past month to those
who did conceal their diagnosis from anyone in the past month. This study also explored
the possibility that differences existed as a function of from whom participants concealed
their diagnosis (described below). Separate analyses were conducted for examining
potential predictors of concealment and correlates of concealment for both time frames
(i.e., within the past month and since the cancer diagnosis).
Logistic regression analyses were used to determine the association between
diagnosis concealment (categorical variable) and hypothesized continuous (e.g.,
introversion) as well as categorical (e.g., gender) predictor variables (Aim 2). Pointbiserial correlational analyses were conducted to determine the associations between
diagnosis concealment and hypothesized correlates of concealment (e.g., depression)
(Aim 3).
Exploratory analyses. Mediational analyses were conducted to explore whether
the expected relationships of concealment with anxiety, depression, and cancer-specific
distress are mediated by social avoidance and self-esteem. These analyses followed
established protocol for determining mediation (Preacher & Hayes, 2008). Preacher &
Hayes (2008) lay out the following steps (see Figure 2):
1. The dependent variable (psychological factor) is regressed on the predictor
(diagnosis concealment). The regression coefficient for the independent
variable (IV) in this equation is termed c.
2. The proposed mediator (avoidance/self-esteem) is regressed on the predictor.
The regression coefficient for the IV in this equation is termed a.
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3. The dependent variable is regressed on the predictor and mediator. The
regression coefficient for the mediator is termed b, and the new regression
coefficient for the predictor in this equation is termed c’.
To satisfy the requirements for mediation the product of ab, the indirect effect,
must be significantly different from zero. Bootstrapping is used to derive an estimate of
and 95% confidence interval for the indirect effect (Preacher & Hayes, 2008), and this
confidence interval is examined to determine whether or not it includes zero.
An exploratory hierarchical logistic regression analysis was planned to determine
whether psychosocial factors accounted for unique variance in diagnosis concealment
above and beyond that contributed by relevant demographic, clinical, and smoking
variables. However, given the lack of support for hypothesized associations between
psychosocial factors and concealment (see below), these logistic regression analyses were
not conducted.
Additional exploratory chi-square analyses were conducted to identify potential
psychological predictors of discomfort associated with concealing or disclosing one’s
diagnosis in the past month. Lastly, an exploratory correlational analysis was conducted
to attempt to replicate the association between perceived stigma and depression observed
by Gonzalez & Jacobsen (2011).
Power analyses. Pilot-testing of the diagnosis concealment measure indicated
that about 30% of lung cancer patients concealed their lung cancer diagnosis from anyone
during treatment. Thus, power analysis for this study presumed that 30% of the sample
would report concealing their diagnosis and 70% will not.
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Hypothesis set 1. A power analysis for a logistic regression was run using Power
and Precision 2.0 (Biostat, 2000). This power analysis indicated that with a Type I error
rate of .05 (two-tailed) and power equal to .80, a sample of 86 participants was necessary
in order to detect an OR = 2.06, which is equivalent to a small to medium effect size (d =
0.4) (Chinn, 2000).
Hypothesis set 2. A power analysis for a point-biserial correlation was run using
Power and Precision 2.0 (Biostat, 2000). This power analysis indicated that with a Type I
error rate of .05 (two-tailed) and power equal to .80, a sample size of 120 participants
would be necessary in order to detect a small to medium effect size of r = .25.
Based on these analyses, the current study aimed to conduct analyses with data
from 120 participants. With the consent of the dissertation committee, analyses were
conducted with data from 117 participants.
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Figure 2. Path diagram for the indirect effect of a predictor on a dependent variable
through a mediator.
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Results
Participants
Participant flow is shown in Figure 3. One thousand four hundred forty-seven
individuals were screened for this study; of these, 1,067 were ineligible based on medical
record reviews (e.g., history of other cancer, not receiving chemotherapy). One hundred
eight-four were potentially eligible for participation but were not approached for
recruitment due to unavailability of research personnel. The remaining 196 participants
were approached for participation; of these, an additional 4 were deemed ineligible
before consent, 39 refused to participate, and 159 agreed to participate (83% of those
eligible). Of those who agreed to participate, 4 withdrew from the study, 29 never
completed the study measures and could not be reached, and 3 were found to be ineligible
after they participated. Thus, analyses were conducted on the 117 participants who had
evaluable data. The 159 patients who agreed to participate in the study did not differ in
terms of age, gender, or race from the 39 patients who declined to participate, ps ≥ .24.
Participant demographic and clinical characteristics are shown in Tables 1 and 2.
Participants ranged in age from 36 to 85 years (M = 64.22; SD = 9.66). The majority of
the participants were high school graduates (70%), married (62%), and White (82%).
Twenty-six participants (22%) were never smokers, and 91 (78%) were previous smokers
or current smokers at the time of the study visit. Mean body mass index for this sample
was 26.33 (SD = 5.19), which indicates that the average participant was slightly
overweight. On average, participants were 20.56 months (SD = 27.92) from their original
20

lung cancer diagnosis. Twenty-seven participants (23%) had a recurrence of their lung
cancer, thirty-seven (32%) had a surgical resection of this cancer, and 50 (43%) had been
treated with radiation therapy.
Prevalence of concealment and reasons for concealment
To address Aim 1, the number of participants who reported concealing their
diagnosis from anyone was calculated using their responses to items asking whether they
concealed from individuals in certain groups (e.g., “Did you choose not to tell a close
family member?”). Concealment was calculated separately for those who concealed from
anyone since their diagnosis and those who concealed from anyone in the past month (see
Tables 3 and 4 for frequencies).
Thirty-six participants (31%) reported concealing since their diagnosis. The
majority (n = 25, 69%) reported concealing from a casual friend since their diagnosis.
Thirty participants (26%) reported concealing in the past month. The majority (n = 20,
67%) reported concealing from a casual friend since their diagnosis.
Reasons for diagnosis concealment are shown in Tables 5 and 6. A commonlyendorsed reason for diagnosis concealment was concern that one’s family or friends
would worry about the patient. This was evident among participants who
concealed since diagnosis and in the past month.
Comparing demographics between concealers and non-concealers
To address hypothesis set 1, comparisons were made between those who
concealed and those who did not on demographic measures (see Tables 7 and 8).
Contrary to expectations, gender was not associated with concealment since diagnosis (p
= .46) or in the past month (p = .67). Exploratory analyses also indicated that age, history
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of smoking, and marital status were not associated with concealment since diagnosis or in
the past month (ps ≥ .07). Additional exploratory analyses indicated that those who
concealed in the past month were more likely to report drinking alcohol in the past month
(p = .04); no differences based on alcohol use were observed for concealment since
diagnosis (p = .09).
Comparing clinical factors between concealers and non-concealers
Exploratory analyses were conducted to identify potential clinical predictors of
concealment (see Tables 9 and 10). Analyses indicated that among patients with a
recurrence, those who recurred more recently were more likely to report concealing in the
past month (p < 0.01); no differences based on recency of recurrence were observed for
concealment since diagnosis (p = .06). Body mass index, time since diagnosis, time since
resection, time since radiation, type of lung cancer (NSCLC vs. SCLC), disease stage,
ECOG performance status, use of antidepressants, and use of sedative/hypnotics were not
associated with diagnosis concealment since diagnosis or in the past month (ps ≥ .06).
Similarly, no associations were found between diagnosis concealment since diagnosis or
in the past month and whether participants had a recurrence, a surgical resection of their
lung cancer, radiotherapy, or chemotherapy (ps ≥ .13).
Examining potential psychological predictors of diagnosis concealment
To address hypothesis set 1, analyses were conducted to identify potential
psychological predictors of concealment (see Tables 11 and 12). Contrary to
expectations, introversion, social anxiety, social support, and use of seeking guidance and
support as a coping strategy were not associated with concealment since diagnosis (ps ≥
.25) or in the past month (ps ≥ .15). In addition to the planned analyses, exploratory
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analyses were conducted to identify potential psychological predictors of diagnosis
concealment (see Tables 13 and 14). Those who reported greater use of positive
reappraisal as a coping strategy were more likely to report concealing their diagnosis in
the past month (p = .02). Private self-consciousness and public self-consciousness were
not associated with diagnosis concealment since diagnosis or in the past month (ps ≥ .13).
In addition, diagnosis concealment since diagnosis or in the past month were not
associated with use of logical analysis, problem-solving, cognitive avoidance, acceptance
or resignation, seeking alternative rewards, or emotional discharge as coping strategies
(ps ≥ .13).
Additional exploratory analyses were conducted to identify potential
psychological predictors of discomfort associated with concealing or disclosing one’s
diagnosis in the past month (see Table 15). Social anxiety was positively associated with
the discomfort participants reported around disclosing or concealing their diagnosis (p <
.01). Discomfort with concealing or disclosing in the past month was not associated with
introversion, social support, or use of seeking guidance and support as a coping strategy
(ps ≥ .48).
Examining potential correlates of concealment
To address hypothesis set 2, analyses were conducted to examine potential
psychological correlates of diagnosis concealment (see Tables 16 and 17). Contrary to
expectations, concealment since diagnosis and in the past month were not associated with
anxiety, depression, cancer-specific distress, social avoidance, and self-esteem (ps ≥ 14).
Additional exploratory analyses were conducted to identify potential stigmarelated psychological correlates of diagnosis concealment (see Tables 18 & 19). Those
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who reported concealing since diagnosis (p = .01) and those who reported concealing in
the past month (p < .01) reported greater internalized shame related to the diagnosis of
lung cancer. Perceived social rejection, financial insecurity, perceived social isolation,
and total perceived stigma were not associated with diagnosis concealment since
diagnosis or in the past month (ps ≥ .20).
Additional exploratory analyses for concealment from close family/friends
Additional exploratory analyses were conducted to identify potential predictors
and correlates of diagnosis concealment from close family or friends versus more distant
others or not at all (see Tables 20, 21, 22, and 23). In order to conduct these analyses, the
sample was dichotomized between those who reported concealing from close family or
friends versus those who did not report concealing or else reported concealing from other
family, work supervisors, co-workers, and/or casual friends. Analyses were conducted
separately for concealment since diagnosis and in the past month. Analyses indicated that
20 (17%) participants reported concealing from close family or friends since their
diagnosis and 15 (13%) reported concealing from close family or friends in the past
month.
Regarding predictors, neither sex, age, smoking history, nor marital status were
associated with concealment from close friends/family since diagnosis (ps ≥ .39) or in the
past month (ps ≥ .18). Poorer social support was associated with concealment from close
family/friends since diagnosis (p = .03) and in the past month (p = .03). Concealment
from close family/friends since diagnosis and in the past month were not associated with
introversion, social anxiety, and use of seeking guidance and support (ps ≥ .07).
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Regarding correlates, diagnosis concealment from close family/friends since
diagnosis and in the past month were not associated with anxiety, depression, cancerspecific distress, social avoidance, and self-esteem (ps ≥ .08).
Mediational analyses
Exploratory mediational analyses were conducted to determine whether the
relationships between concealment (since diagnosis and in the past month) and affective
correlates were mediated by social avoidance and self-esteem. Self-esteem did not
mediate the relationships between diagnosis concealment (since diagnosis or in the past
month) with anxiety, depression, or cancer-specific distress, ps > .05. Social avoidance
did not mediate the relationships between diagnosis concealment (since diagnosis or in
the past month) with anxiety, depression, and cancer-specific distress, ps > .05.
Additional exploratory analysis
An additional exploratory analysis was conducted to examine whether perceived
stigma was associated with depression. Greater perceived stigma was associated with
greater depressive symptomatology, r(114) = .35, p < .01.
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Table 1
Demographic Characteristics of the Sample (N = 117)

Variable

M

SD

Age, years

64.22

(9.66)

Pack years of tobacco usea

42.52

(29.96)

Variable

n

%

Gender
Males
Females

58
59

(49.6%)
(50.4%)

Education
≤ High school graduate
> High school graduate

35
82

(29.9%)
(70.1%)

Race
White
Non-white

96
21

(82.1%)
(17.9%)

5
112

(4.3%)
(95.7%)

Marital Status
Currently married
Not married

73
44

(62.4%)
(37.6%)

Total household income
< $ 40,000
≥ $40,000
Declined to answer

29
69
19

(24.8%)
(59.0%)
(16.2%)

Alcohol use in past month
No
Yes

69
48

(59.0%)
(41.0%)

Cigarette use
Never
Previous & current

26
91

(22.2%)
(77.7%)

Ethnicity
Hispanic
Non-hispanic

Note. aAmong only past smokers and current smokers (n = 91).
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Table 2
Clinical Characteristics of the Sample (N = 117)

Variable

M

SD

Body mass index

26.33

(5.19)

Months since original diagnosis

20.56

(27.92)

Months since recurrencea

9.74

(9.53)

Months since resectionb

26.46

(32.75)

Months since radiationc

13.40

(21.70)

n

%

Type of lung cancer
NSCLC
SCLC

104
13

(88.9%)
(11.1%)

NSCLC disease staged
I – II
III
IV

14
17
73

(12.0%)
(14.5%)
(62.4%)

SCLC disease stagee
Limited stage SCLC
Extensive stage SCLC

2
11

(15.4%)
(84.6%)

ECOG performance status
0
1
2-4

23
84
10

(19.7%)
(71.8%)
(8.5%)

Taking antidepressant medication at time of study visit
No
Yes

92
25

(78.6%)
(21.4%)

Taking sedative/hypnotic medication at time of study visit
No
67
Yes
50

(57.3%)
(42.7%)

Variable
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Table 2 (Continued)
Had a recurrence
No
Yes

90
27

(76.9%)
(23.1%)

Had resection of this cancer
No
Yes

80
37

(68.4%)
(31.6%)

Had radiation therapy for this cancer
Never
Finished radiation before consent
Receiving radiation

67
42
8

(57.3%)
(35.9%)
(6.8%)

Had chemotherapy for this cancer
Never
Receiving chemotherapy

1
116

(0.9%)
(99.1%)

Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27).
b
Among only those with a resection (n = 37). cAmong only those with radiation (n = 50).
d
Among only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13).
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Table 3
Frequencies of Concealment Since Diagnosis From Various Groups (n = 36)
Concealment From

Yes

No

N/A

Sum

Close family

11 (30.6%)

25 (69.4%)

--

36

Other family

10 (27.8%)

26 (72.2%)

--

36

2 (5.6%)

12 (33.3%)

22 (61.1%)

36

Co-worker

4 (11.1%)

8 (22.2%)

24 (66.7%)

36

Close friend

13 (36.1%)

23 (63.9%)

--

36

Casual friend

25 (69.4%)

11 (30.6%)

--

36

Work supervisor
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Table 4
Frequencies of Concealment in Past Month From Various Groups (n = 30)
Concealment From

Yes

No

N/A

Sum

Close family

5 (16.7%)

25 (83.3%)

--

30

Other family

8 (26.7%)

22 (73.3%)

--

30

0 (0.0%)

13 (43.3%)

17 (56.7%)

30

Co-worker

4 (13.3%)

6 (20.0%)

20 (66.7%)

30

Close friend

12 (40.0%)

18 (60.0%)

--

30

Casual friend

20 (66.7%)

10 (33.3%)

--

30

Work supervisor
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Table 5
Frequencies of Reasons for Concealment From Various Groups
Since Diagnosis (N = 117)
Concealment From

n

%

I didn’t want them to worry about me

4

36.4%

Other

3

27.3%

I didn’t want to overburden them

2

18.2%

Missing

2

18.2%

I didn’t want them to worry about me

6

60.0%

I didn’t want them to take pity on me

3

30.0%

I didn’t want to overburden them

1

10.0%

They might think I’d take too much time off

1

50.0%

Other

1

50.0%

Other

2

60.0%

I didn’t want to overburden them

1

20.0%

I was concerned that they might judge me

1

20.0%

I didn’t want them to worry about me

7

53.8%

I didn’t want them to take pity on me

4

30.8%

I didn’t want to overburden them

1

7.7%

Other

1

7.7%

Close family

Other family

Work supervisor

Co-worker

Close friend

Casual friend
Other

11 44.0%

I didn’t want them to take pity on me

8

32.0%

I didn’t want them to worry about me

4

16.0%

I didn’t want to overburden them

1

4.0%

I thought they might avoid me

1

4.0%
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Table 6
Frequencies of Reasons for Concealment From Various Groups in the
Past Month (N = 117)
Concealment From

n

%

I didn’t want to overburden them

2

40.0%

I didn’t want them to worry about me

1

20.0%

Other

1

20.0%

Missing

1

20.0%

I didn’t want them to worry about me

5

62.5%

I didn’t want them to take pity on me

2

25.0%

I didn’t want to overburden them

1

12.5%

Other

3

75.0%

I was concerned that they might judge me

1

25.0%

I didn’t want them to worry about me

7

58.3%

I didn’t want them to take pity on me

3

5.0%

I didn’t want to overburden them

1

8.3%

Other

1

830.0%

Other

10

52.6%

I didn’t want them to take pity on me

6

31.6%

I didn’t want them to worry about me

2

10.5%

I didn’t want to overburden them

1

4.0%

Close family

Other family

Co-worker

Close friend

Casual friend

32

Table 7
Demographics of Participants Who Did Not Conceal Compared to Those Who Did
Conceal
Since Diagnosis (N = 117)

(n = 36)

Did not
conceal
(n = 81)

M (SD)

M (SD)

t

P

Age, years

62.7 (10.44)

64.9 (9.25)

1.15

.26

Pack years of tobacco usea

45.9 (30.22)

39.9 (28.65)

-.90

.37

χ2

p

0.55

.46

0.60

.44

0.65

.42

0.21

.65

1.04

.31

0.82

.66

Did conceal

Variable

Variable

n (%)

n (%)

Gender
Males

16 (13.7%)

42 (35.9%)

Females

20 (17.1%)

39 (33.3%)

Education
≤ High school graduate

9 (7.7%)

26 (23.1%)

> High school graduate

26 (22.2%)

55 (47.0%)

Race
White
Non-white

28 (23.9%)

68 (58.1%)

8 (6.8%)

13 (11.1%)

Ethnicity
Hispanic
Non-hispanic

2 (1.7%)

3 (2.6%)

34 (29.1%)

78 (66.7%)

Marital status
Currently married

20 (17.1%)

53 (45.3%)

Not married

16 (13.7%)

28 (23.9%)

Total household income
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Table 7 (Continued)
< $ 40,000

7 (6.0%)

22 (18.8%)

≥ $40,000

23 (19.7%)

46 (39.3%)

6 (5.1%)

13 (11.1%)

Declined to answer
Alcohol use in past month
No

17 (14.5%)

52 (44.4%)

Yes

19 (16.2%)

29 (24.8%)

Cigarette use
Never
Previous & current

9 (7.7%)

17 (14.5%)

27 (23.1%)

64 (54.7%)

Note. aAmong only past smokers and current smokers (n = 91).
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2.97

.09

0.23

.63

Table 8
Demographics of Participants Who Did Not Conceal Compared to Those Who Did
Conceal
in the Past Month (N = 117)

(n = 30)

Did not
conceal
(n = 87)

Variable

M (SD)

M (SD)

Age, years

61.47 (9.93)

Pack years of tobacco usea
Variable

Did conceal

t

P

65.17 (9.40)

1.84

.07

46.48 (33.62)

40.22 (27.67)

-0.86

.39

n (%)

n (%)

χ2

P

0.81

.67

0.83

.36

2.08

.15

0.57

.45

0.02

.90

0.99

.61

Gender
Males

17 (14.5%)

41 (35.1%)

Females

13 (11.1%)

46 (39.3%)

Education
≤ High school graduate

7 (6.0%)

28 (23.9%)

> High school graduate

23 (19.7%)

59 (50.4%)

Race
White

22 (18.8%)

74 (63.2%)

Non-white

8 (6.8%)

13 (11.1%)

Ethnicity
Hispanic

2 (1.7%)

3 (2.6%)

Non-hispanic

28 (23.9%)

84 (71.8%)

Marital status
Currently married

19 (16.2%)

54 (46.2%)

Not married

11 (9.4%)

33 (28.2%)

Total household income
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Table 8 (Continued)
< $ 40,000

6 (5.1%)

23 (19.7%)

≥ $40,000

20 (17.1%)

49 (41.9%)

Declined to answer

4 (3.4%)

15 (12.8%)

Alcohol use in past month
No

13 (11.1%)

56 (47.9%)

Yes

17 (14.5%)

31 (26.5%)

Cigarette use
Never

9 (7.7%)

17 (14.5%)

Previous & current

21 (17.9%)

70 (59.8%)

Note. aAmong only past smokers and current smokers (n = 91).
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4.08

.04

1.41

.24

Table 9
Clinical Characteristics of Participants Who Did Not Conceal Compared to Those Who
Did Conceal Since Diagnosis (N = 117)

(n = 36)

Did not
conceal
(n = 82)

M (SD)

M (SD)

t

P

Body mass index

26.2 (4.97)

26.4 (5.31)

0.20

.85

Months since original diagnosis

23.0 (29.60)

19.5 (27.26)

-0.64

.53

Months since recurrencea

5.6 (5.99)

12.6 (10.61)

1.95

.06

Months since resectionb

31.2 (34.51)

24.2 (32.35)

-0.60

.55

Months since radiationc

20.2 (34.86)

11.0 (14.60)

-1.33

.19

χ2

p

0.41

.52

0.05

> .99

0.13

.72

2.67

.45

Did conceal

Variable

Variable

n (%)

n (%)

Type of lung cancer
NSCLC
SCLC

31 (26.5%)

73 (62.4%)

5 (4.3%)

8 (6.8%)

NSCLC disease staged
I – II

4 (3.8%)

10 (9.6%)

III

5 (4.8%)

12 (11.5%)

IV

21 (21.2%)

51 (49.0%)

SCLC disease stagee
Limited stage SCLC

1 (7.7%)

1 (7.7%)

Extensive stage SCLC

4 (30.8%)

7 (53.8%)

ECOG performance status
0

10 (8.5%)

13 (11.1%)

1

23 (19.7%)

61 (52.1%)

3 (2.6%)

7 (6.0%)

2–4
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Table 9 (Continued)
Taking antidepressant medication
0.11

.74

0.02

.87

1.64

.20

0.07

.79

1.52

.47

2.27

.13

at time of study visit
No

29 (24.8%)

63 (53.8%)

Yes

7 (6.0%)

18 (15.4%)

Taking sedative/hypnotic medication
at time of study visit
No

21 (17.9%)

46 (39.3%)

Yes

15 (12.8%)

35 (29.9%)

Had a recurrence
No

25 (21.4%)

65 (55.6%)

Yes

11 (9.4%)

16 (13.7%)

Had resection of this cancer
No

24 (20.5%)

56 (47.9%)

Yes

12 (10.3%)

25 (21.4%)

Had radiation therapy for this cancer
Never
Finished radiation before
consent
Receiving radiation

23 (19.7%)

44 (37.6%)

10 (8.5%)

32 (27.4%)

3 (2.6%)

5 (4.3%)

Had chemotherapy for this cancer
Never
Receiving chemotherapy

1 (0.9%)

0 (0.0%)

35 (29.9%)

81 (69.2%)

Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27).
b
Among only those with a resection (n = 37). cAmong only those with radiation (n = 50).
d
Among only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13).
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Table 10
Clinical Characteristics of Participants Who Did Not Conceal Compared to Those Who
Did Conceal in the Past Month (N = 117)

(n = 30)

Did not
conceal
(n = 82)

M (SD)

M (SD)

t

p

Did conceal

Variable
Body mass index

25.79 (4.97)

26.52 (5.27)

0.66

.51

Months since original
diagnosis

22.03 (30.94)

20.05 (26.97)

-0.34

.74

Months since recurrencea

4.22 (2.73)

12.50 (10.55)

3.13

< .01

Months since resectionb

31.17 (34.51)

24.20 (32.35)

-0.60

.55

Months since radiationc

19.83 (36.35)

11.37 (15.00)

-1.18

.24

n (%)

χ2

p

3.23

.07

0.56

.91

0.01

.91

3.00

.39

Variable

n (%)

Type of lung cancer
NSCLC

24 (20.5%)

80 (68.4%)

SCLC

6 (5.1%)

7 (6.0%)

NSCLC disease staged
I - II

4 (3.8%)

10 (9.6%)

III

3 (2.9%)

14 (13.5%)

IV

17 (16.3%)

56 (53.8%)

SCLC disease stagee
Limited stage SCLC

1 (7.7%)

1 (7.7%)

Extensive stage SCLC

5 (38.5%)

6 (46.2%)

ECOG performance status
0

9 (7.7%)

14 (12.0%)

1

19 (16.2%)

65 (55.6%)

2-4

2 (1.7%)

8 (6.9%)
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Table 10 (Continued)
Taking antidepressant medication at time of study visit
No

23 (19.7%)

69 (59.0%)

Yes

7 (6.0%)

18 (15.4%)

Taking sedative/hypnotic medication at time of study visit
No

20 (17.1%)

47 (40.2%)

Yes

10 (8.5%)

40 (34.2%)

Had a recurrence
No

21 (17.9%)

69 (59.0%)

Yes

9 (7.7%)

18 (15.4%)

Had resection of this cancer
No

18 (15.4%)

62 (53.0%)

Yes

12 (10.3%)

25 (21.4%)

Had radiation therapy for this cancer
Never
Finished radiation before
consent
Receiving radiation

18 (15.4%)

49 (41.9%)

10 (8.5%)

32 (27.4%)

2 (1.7%)

6 (5.1%)

Had chemotherapy for this cancer
Never

0 (0.0%)

1 (0.9%)

Receiving chemotherapy

30 (25.6%)

86 (73.5%)

0.09

.76

1.46

.23

1.09

.30

1.31

.25

0.13

.94

0.35

.56

Note. ECOG = Eastern Cooperative Oncology Group. NSCLC = non-small cell lung
cancer. SCLC = small cell lung cancer. aAmong only those with a recurrence (n = 27).
b
Among only those with a resection (n = 37). cAmong only those with radiation (n = 50).
d
Among only those with NSCLC (n = 104). eAmong only those with SCLC (n = 13).
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Table 11
Psychological Predictors of Concealment in Participants Who Did Not Conceal
Compared to Those Who Did Conceal Since Diagnosis (N = 117).

Variable

Did conceal

Did not conceal

(n = 36)

(n = 80)

M (SD)

M (SD)

Wald χ2

p

Introversion

27.1 (7.02)

28.6 (6.34)

1.32

.25

Social Anxiety

12.5 (10.33)

13.7 (12.68)

0.26

.61

Social Support

22.2 (4.06)

22.5 (3.72)

0.01

.92

Seeking Guidance & Support

52.4 (8.09)

53.9 (8.52)

0.74

.39
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Table 12
Psychological Predictors of Concealment in Participants Who Did Not
Conceal Compared to Those Who Did Conceal in the Past Month (N = 117)
Did conceal Did not conceal
(n = 30)

(n = 87)

M (SD)

M (SD)

Wald χ2

p

Introversion

26.6 (6.39)

28.6 (6.58)

2.12

.15

Social Anxiety

12.2 (10.72)

13.7 (12.42)

0.39

.54

Social Support

22.1 (3.93)

22.5 (3.79)

0.03

.85

Seeking Guidance & Support

53.9 (8.16)

53.3 (8.50)

0.09

.77

Variable
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Table 13
Psychological Predictors of Concealment in Participants Who Did Not
Conceal Compared to Those Who Did Conceal Since Diagnosis (N = 117)

Did conceal

Did not conceal

(n = 36)

(n = 80)

M (SD)

M (SD)

Wald χ2

p

Private Self-Consciousness

12.69 (4.33)

11.36 (4.23)

2.30

.13

Public Self-Consciousness

12.40 (5.83)

10.43 (6.60)

2.15

.14

CRI Logical Analysis

46.14 (7.46)

45.06 (15.75)

0.13

.72

CRI Positive Reappraisal

55.00 (6.39)

53.22 (8.34)

1.17

.28

CRI Problem-Solving

52.88 (6.46)

52.15 (8.75)

0.17

.68

CRI Cognitive Avoidance

49.66 (8.16)

50.96 (8.76)

0.51

.48

CRI Acceptance or Resignation

51.08 (10.20)

49.19 (8.35)

0.99

.32

CRI Seeking Alternative Rewards 51.76 (9.89)

53.52 (9.19)

0.78

.38

CRI Emotional Discharge

51.33 (8.13)

2.27

.13

Variable

54.02 (9.08)

Note. CRI = Coping Responses Inventory. SIS = Social Impact Scale.

43

Table 14
Psychological Predictors of Concealment in Participants Who Did Not
Conceal Compared to Those Who Did Conceal in the Past Month (N = 117)

Did conceal

Did not conceal

(n = 30)

(n = 87)

M (SD)

M (SD)

Wald χ2

p

Private Self-Consciousness

12.76 (4.01)

11.43 (4.34)

2.07

.15

Public Self-Consciousness

12.52 (5.70)

10.52 (6.60)

1.96

.16

CRI Logical Analysis

46.26 (8.14)

45.09 (15.27)

0.14

.71

CRI Positive Reappraisal

56.94 (4.64)

52.70 (8.39)

5.63

.02

CRI Problem-Solving

52.66 (5.88)

52.27 (8.72)

0.04

.84

CRI Cognitive Avoidance

49.97 (8.63)

50.78 (8.61)

0.18

.67

CRI Acceptance or Resignation

50.03 (10.34)

49.64 (8.61)

0.04

.85

CRI Seeking Alternative Rewards 52.35 (9.92)

53.22 (9.26)

0.17

.68

CRI Emotional Discharge

51.78 (8.55)

0.54

.46

Variable

53.18 (8.24)

Note. CRI = Coping Responses Inventory. SIS = Social Impact Scale.

44

Table 15
Psychological Predictors of Discomfort With Concealing or Disclosing One’s Diagnosis
in the Past Month (N = 117)

Introversion

Social
Anxiety

Social
Support

Seeking
Guidance &
Support

n (%)

M (SD)

M (SD)

M (SD)

M (SD)

51 (43.6%)

28.02 (6.24)

9.82 (10.83)

22.78 (3.61)

53.28 (8.86)

24 (20.5%)

28.29 (6.71)

15.21 (10.40)

22.17 (3.20)

53.96 (7.72)

19 (16.2%)

28.00 (7.36)

18.68 (15.2)

21.72 (3.80)

54.41 (8.01)

16 (13.7%)

26.06 (5.70)

16.07 (12.50)

20.81 (6.63)

50.40 (8.68)

7 (6.0%)

33.43 (7.09)

12.07 (8.06)

23.43 (3.31)

57.79 (6.54)

rho = .009

rho = .265

rho = -.066

rho = .011

p = .92

p < .01

p = .48

p = .91

Discomfort
level

No
discomfort
A little
discomfort
Mild
discomfort
Moderate
discomfort
Extreme
discomfort
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Table 16
Psychological Correlates of Concealment in Participants Who Did Conceal Compared to
Those Who Did Not Conceal Since Diagnosis (N = 117)

Did conceal

Did not conceal

(n = 36)

(n = 80)

Variable

M (SD)

M (SD)

r

p

Anxiety

13.06 (3.14)

12.44 (3.50)

.085

.37

Depression

14.03 (2.98)

14.11 (2.80)

-.014

.88

Cancer-Specific Distress

0.78 (0.73)

0.90 (0.73)

-.074

.43

Social Avoidance

16.49 (10.26)

18.25 (13.31)

-.066

.48

Self-Esteem

23.91 (4.95)

22.32 (5.37)

.160

.14
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Table 17
Psychological Correlates of Concealment in Participants Who Did Not Conceal
Compared to
Those Who Did Conceal in the Past Month (N = 117)

Did conceal

Did not conceal

(n = 30)

(n = 87)

Variable

M (SD)

M (SD)

r

p

Anxiety

13.40 (2.93)

12.36 (3.52)

.135

.15

Depression

14.10 (3.10)

14.08 (2.77)

.003

.98

Cancer-Specific Distress

0.81 (0.76)

0.89 (0.72)

-.045

.64

Social Avoidance

17.17 (10.55)

17.89 (13.06)

-.026

.79

Self-Esteem

23.10 (5.07)

22.70 (5.37)

.033

.72
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Table 18
Psychological Correlates of Concealment in Participants Who Did Not Conceal
Compared to Those Who Did Conceal Since Diagnosis (N = 117)

Did conceal

Did not conceal

(n = 36)

(n = 80)

M (SD)

M (SD)

r

p

SIS Social Rejection

12.72 (3.15)

13.65 (4.31)

-.108

.25

SIS Financial Insecurity

4.25 (1.99)

4.84 (2.37)

-.120

.20

SIS Internalized Shame

9.61 (2.50)

8.36 (2.50)

.227

.01

SIS Social Isolation

13.42 (3.59)

13.66 (4.51)

-.027

.77

SIS Total Perceived Stigma

40.00 (8.48)

40.51 (11.25)

-.023

.81

Variable

Note. SIS = Social Impact Scale.
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Table 19
Psychological Correlates of Concealment in Participants Who Did Not Conceal
Compared to Those Who Did Conceal in the Past Month (N = 117)

Did conceal

Did not conceal

(n = 30)

(n = 87)

M (SD)

M (SD)

r

p

SIS Social Rejection

13.60 (3.32)

13.28 (4.22)

.035

.71

SIS Financial Insecurity

4.50 (2.13)

4.71 (2.32)

-.041

.67

SIS Internalized Shame

9.93 (2.59)

8.34 (2.42)

.275

< .01

SIS Social Isolation

13.93 (3.37)

13.47 (4.51)

.049

.60

SIS Total Perceived Stigma

41.97 (8.42)

39.79 (11.03)

.092

.33

Variable

Note. SIS = Social Impact Scale.
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Table 20
Psychological Predictors of Concealment in Participants Who Did Not Conceal From
Close Family/Friends Compared to Those Who Did Conceal Since Diagnosis (N = 117)

Did conceal from

Did not conceal

close family/friends
(n = 20)

(n = 97)

M (SD)

M (SD)

Wald χ2

p

Introversion

26.85 (8.24)

28.40 (6.18)

0.92

.34

Social Anxiety

9.58 (8.43)

14.11 (12.48)

2.32

.13

Social Support

20.58 (4.74)

22.59 (3.89)

4.59

.03

Seeking Guidance & Support

53.01 (8.23)

53.55 (8.46)

0.07

.80

Variable
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Table 21
Psychological Correlates of Concealment in Participants Who Did Not Conceal From
Close Family/Friends Compared to Those Who Did in the Past Month (N = 117)

Did conceal from

Did not conceal

close family/friends
(n = 15)

(n = 102)

M (SD)

M (SD)

Wald χ2

p

Introversion

25.20 (6.81)

28.56 (6.45)

3.34

.07

Social Anxiety

10.13 (9.29)

13.81 (12.29)

1.22

.97

Social Support

20.14 (4.37)

22.55 (3.98)

4.82

.03

Seeking Guidance & Support

52.48 (8.20)

53.60 (8.45)

0.22

.64

Variable
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Table 22
Psychological Correlates of Concealment in Participants Who Did Not Conceal From
Close Family/Friends Compared to Those Who Did Conceal Since Diagnosis (N = 117)

Did conceal from

Did not conceal

close family/friends
(n = 20)

(n = 97)

Variable

M (SD)

M (SD)

r

p

Anxiety

13.45 (3.35)

12.46 (3.40)

.105

.26

Depression

13.90 (3.18)

14.13 (2.78)

-.023

.81

Cancer-Specific Distress

0.74 (0.75)

0.89 (0.73)

-.082

.38

Social Avoidance

15.23 (9.77)

18.22 (12.89)

-.085

.37

Self-Esteem

23.58 (5.71)

22.65 (5.20)

.143

.16
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Table 23
Psychological Correlates of Concealment in Participants Who Did Not Conceal From
Close Family/Friends Compared to Those Who Did Conceal In the Past Month (N =
117)

Did conceal from

Did not conceal

close family/friends
(n = 15)

(n = 102)

Variable

M (SD)

M (SD)

Anxiety

14.07 (2.46)

12.42 (3.47)

.162

.08

Depression

13.80 (3.38)

14.13 (2.77)

-.017

.86

Cancer-Specific Distress

0.81 (0.82)

0.87 (0.72)

-.041

.66

Social Avoidance

17.33 (10.15)

17.76 (12.76)

-.021

.82

Self-Esteem

22.71 (5.90)

22.81 (5.21)

.056

.59
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r

p

Assessed for eligibility
(n= 1,447)
Ineligible for participation
(n = 1,067)
Potentially eligible, but not
approached (n = 184)
Approached for consent
(n = 196)
Ineligible before consent
(n = 4)

Refused to participate
(n = 39)

Consented
(n = 153)
Ineligible after consent
(n = 3)

Withdrew from study
(n = 4)

Failed to complete measures
(n = 29)
Completed study measures
(n = 117)

Figure 3. Participant Flow Chart
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Discussion
Summary of Results
A primary aim of this study was to determine the prevalence of diagnosis
concealment among individuals receiving treatment for lung cancer. This study also
sought to evaluate potential predictors of concealment as well as potential correlates of
concealment.
Results indicated that 31% of participants reported concealing their lung cancer
diagnosis from others since their diagnosis; 26% reported concealing their diagnosis in
the month preceding their participation in the study. Most participants who reported
concealing since diagnosis as well as in the past month indicated they concealed from
casual friends. Additional analyses indicated that one commonly-endorsed reason for
concealment from family and friends was to avoid having family and friends worry about
the patient. No published quantitative studies were found which examine rates of
concealment of one’s cancer diagnosis or any other potentially-stigmatizing condition.
Thus, this is the first study to examine rates of diagnosis concealment among individuals
with cancer, and as such it provides new information on rates of concealment and reasons
for concealment among this population.
The hypotheses regarding predictors of concealment were not supported. Contrary
to expectations, gender, introversion, trait social anxiety, and use of seeking guidance and
support as a coping strategy were not associated with diagnosis concealment since
diagnosis or in the past month. Exploratory analyses indicated that those who reported
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drinking alcohol in the past month were more likely to conceal their diagnosis in the past
month; there was also a trend for those who reported drinking alcohol in the past month
to be more likely to conceal since diagnosis. Participants who had a recurrence of their
lung cancer more recently were more likely to conceal their diagnosis in the past month;
there was a trend for a similar relationship suggesting that those who recurred more
recently were also more likely to conceal their diagnosis since the original diagnosis. In
addition, those who reported greater use of positive reappraisal as a coping tool were
more likely to conceal their diagnosis in the past month. Trait social anxiety was related
to discomfort regarding concealment or disclosure of one’s diagnosis in the past month.
Lastly, those who concealed their diagnosis from close family or friends since diagnosis
and in the past month reported poorer social support.
The Pachankis (2007) model of the effects of concealing a concealable stigma is
silent on theoretical predictors of the decision to conceal one’s stigma. Although
hypotheses for predictors of concealment based on findings in other populations were not
supported, use of alcohol, recency of a recurrence of lung cancer, use of positive
reappraisal as a coping strategy, and social support were identified as predictors of
concealment among individuals with lung cancer. The observed relationship between
poorer social support and concealment is in line with previous literature showing poorer
social support among those who concealed a diagnosis of HIV (Petrak et al., 2001). This
finding suggests the Pachankis (2007) model may benefit from revision to include social
support. Relationships between concealment with use of alcohol, recency of recurrence of
lung cancer, and use of positive reappraisal as a coping strategy have not been found in
the existing literature. Individuals with more recent recurrences have experienced a major
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setback in their lung cancer treatment, which may reinforce the reported reasons to
conceal their diagnosis (e.g., to avoid others’ concern for them). Those who used of
alcohol, which may be an indicator of a maladaptive coping strategy, may be more likely
to resort to concealment when considering the potential negative psychosocial outcomes
of disclosing their illness. Similarly, those who endorsed greater use of positive
reappraisal as a coping strategy, an adaptive coping strategy, may have been more likely
to focus on the positive aspects of concealment (e.g., greater privacy). These findings
should be considered for inclusion as predictors in the model, pending replications.
Hypotheses regarding correlates of concealment were also not supported.
Anxiety, depression, cancer-specific distress, social avoidance, and self-esteem were not
associated with diagnosis concealment since diagnosis or in the past month. Exploratory
analyses indicated that those who concealed their diagnosis since diagnosis and in the
past month reported greater internalized shame regarding their diagnosis. The
identification of internalized shame as a correlate of diagnosis concealment is important
in that it supports the Pachankis (2007) model’s association between concealment and
shame, an affective implication of concealment.
Theoretical implications
When contemplating the lack of support for hypotheses of correlates of
concealment, it is important to consider that Pachankis’ (2007) model focuses on
individual situations that might elicit behavioral, affective, and cognitive consequences. It
indicates that among individuals who conceal a stigma, situations in which one’s stigma
is salient, there is a high threat of discovery, and there would be negative consequences
for discovery would result in negative affective, behavioral, and self-evaluative
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outcomes. Rather than examining the social interactions of participants who concealed
their stigma, this study examined broader implications of concealing one’s stigma based
on the model’s theorized. Thus, it is possible that the negative consequences of
concealing one’s stigma and undergoing situations with high stigma salience, high threat
of discovery, and dire consequences of discovery were not detectable by this study’s
measures or were not significant enough to impact participants’ overall well-being. That
is, concealing a concealable stigma such as lung cancer may result in negative
consequences during and after the above-mentioned situations. However, these negative
consequences may be short-lived and go unnoticed in a retrospective study such as the
current study.
Another possible explanation for the lack of support for the study’s hypotheses
involves the reasons for concealment. Many participants reported concealing for what
appeared to be altruistic reasons (e.g., “I didn’t want them to worry about me”). Thus, it
is possible that the situations within which the study’s participants concealed their stigma
did not meet the description provided by Pachankis of situations that would elicit
negative consequences. Specifically, these situations may not have possessed sufficiently
high threat of negative consequences for disclosure of one’s stigma. That is, the potential
negative consequence of disclosure (i.e., their loved one’s excessive worry about them),
may not have been sufficiently negative to elicit the negative affective, behavioral, and
self-evaluative consequences proposed by Pachankis (2007).
Clinical implications
With regard to clinical implications, the findings suggest that oncologists and
mental healthcare professionals treating individuals with cancer consider discussing
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concealment or disclosure of their diagnosis with their patients. The data suggest that
those who conceal their illness may be more likely to experience internalized shame
regarding their illness. Although concealment was not associated with affective outcomes
in this study, internalized shame has been associated with greater depressive
symptomatology among individuals with lung cancer in previous research (Gonzalez &
Jacobsen, 2011) and perceived stigma was associated with depressive symptoms in the
current study. Addressing this potential impact of concealment of one’s diagnosis could
prove beneficial in avoiding depressive symptoms and their negative sequelae if, as
hypothesized by Pachankis (2007), concealment results in greater shame. It is also
conceivable that one’s internalized shame may cause them to conceal their diagnosis,
which may result in other negative behavioral, affective, and cognitive outcomes.
Limitations and future directions
The cross-sectional nature of this study’s data collection limits the conclusions
that can be drawn from its findings. Although the data can be interpreted as suggesting
that use of positive reappraisal as a coping strategy, greater trait social anxiety, and
poorer social support increase the likelihood that a person with lung cancer will conceal
their diagnosis and that concealment contributes to greater internalized shame, the
possibility of reverse relationships between these measures cannot be ruled out. One way
to better establish causality would be to conduct in vivo studies that examine the impact
of concealing vs. disclosing a lung cancer diagnosis to confederate strangers. These
studies could more closely examine the impacts of concealing in various situations and
could elucidate temporal relationships between predictors and consequences of
concealment.
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The sample’s homogeneity with regard to race and ethnicity limits the ability to
generalize to the broader population of individuals with lung cancer. Future studies
should aim to recruit more diverse samples of individuals with lung cancer, especially
with respect to racial, ethnic, and socioeconomic diversity. Similarly, participants in this
study were receiving chemotherapy and/or radiotherapy for their lung cancer; thus, the
study’s findings may not generalize to individuals receiving other types of treatments or
receiving no treatment at all.
Although the prescription of antidepressant and sedative/hypnotic medications
were not related to concealment in this study, participants’ use of psychotherapy and
related services was not assessed. Thus, the potential buffering effect of these services
could not be ascertained. Future studies should more closely examine the impacts that
psychotherapy and related services may have on the negative outcomes hypothesized to
result from concealment.
Another limitation of this study is the treatment of concealment as a dichotomous
variable. This approach may have artificially increased the error in the measurement of
concealment, thereby reducing the study’s power to identify significant effects. Future
studies should examine the frequency of concealment or study concealment as a
continuous variable by measuring the varying degrees of concealment from others. In
addition, the validity of the concealment measure used in this study should be better
established. Future studies should examine whether patient reports of diagnosis
concealment or disclosure could be corroborated with reports from significant others in a
manner that would not violate patient privacy.
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Beyond addressing these limitations, future research should examine the
possibility that concealment or disclosure results in negative consequences for only
certain subgroups of individuals. For example, it may be that only those with greater
social anxiety experience poorer self-esteem as a result of concealment. It may also be
that only those with poorer social support experience greater social avoidance and
depression as a result of concealment.
Conclusions
This study, the first to examine predictors of diagnosis concealment and to test a
model of the impacts of concealment on individuals with cancer, demonstrated that 31%
of participants concealed their diagnosis from others since their diagnosis and 26%
concealed their diagnosis in the month preceding their participation in the study.
Exploratory analyses identified predictors of concealment, including use of alcohol,
recency of a recurrence of lung cancer, use of positive reappraisal as a coping strategy,
and social support. Internalized shame was also identified as a correlate of concealment
in this study. These findings support parts of the Pachankis (2007) model on the effects of
concealment and suggest that the model should be modified to include predictors of
concealment. Future research should aim to replicate these findings and examine
predictors and consequences of concealment in the context of certain social situations in
order to test temporal relationships.

61

References

Biostat. (2000). Power and precision [computer software]. Englewood, NJ:

Boehmer, U., & Clark, J. A. (2001). Communication about prostate cancer between men
and their wives. Journal of Family Practice, 50(3), 226-234.

Brewin, C. R., Watson, M., McCarthy, S., Hyman, P., & Dayson, D. (1998). Intrusive
memories and depression in cancer patients. Behaviour Research and Therapy,
36(12), 1131-1142.

Cepeda-Benito, A., & Short, P. (1998). Self-concealment, avoidance of psychological
services, and perceived likelihood of seeking professional help. Journal of
Counseling Psychology, 45(1), 58-64.

Chan, Y. M., Ng, T. Y., Lee, P. W. H., Ngan, H. Y. S., & Wong, L. C. (2003).
Symptoms, coping strategies, and timing of presentations in patients with newly
diagnosed ovarian cancer. Gynecologic Oncology, 90(3), 651-656.

Chapple, A., Ziebland, S., & McPherson, A. (2004). Stigma, shame, and blame
experienced by patients with lung cancer: Qualitative study. British Medical Journal,
328(7454), 1470-1474. doi:10.1136/bmj.38111.639734.7C

62

Chinn, S. (2000). A simple method for converting an odds ratio to effect size for use in
meta-analysis. Statistics in Medicine, 19(22), 3127-3131.

Costa Jr, P. T., & McCrae, R. R. (1992). Revised NEO personality inventory (NEO PI-R)
and NEO five-factor inventory (NEO-FFI). Odessa, FL: Psychological Assessment
Resources, Inc.

Cramer, K. M., & Lake, R. P. (1998). The preference for solitude scale: Psychometric
properties and factor structure. Personality and Individual Differences, 24(2), 193199.

Donovan, T., & Flynn, M. (2007). What makes a man a man?: The lived experience of
male breast cancer. Cancer Nursing, 30(6), 464-470.

Endler, N. S., Flett, G. L., Macrodimitris, S. D., Corace, K. M., & Kocovski, N. L.
(2002). Separation, self-disclosure, and social evaluation anxiety as facets of trait
social anxiety. European Journal of Personality, 16(4), 239-269.

Fife, B. L., & Wright, E. R. (2000). The dimensionality of stigma: A comparison of its
impact on the self of persons with HIV/AIDS and cancer. Journal of Health and
Social Behavior, 41(1), 50-67.

Floyd, A., Dedert, E., Ghate, S., Salmon, P., Weissbecker, I., Studts, J. L., . . . Sephton, S.
E. (2011). Depression may mediate the relationship between sense of coherence and
quality of life in lung cancer patients. Journal of Health Psychology, 16(2), 249-257.

63

Frable, D. E. S., Platt, L., & Hoey, S. (1998). Concealable stigmas and positive selfperceptions: Feeling better around similar others. Journal of Personality and Social
Psychology, 74(4), 909-922.

Gonzalez, B. D., & Jacobsen, P. B. (2011). Depression in lung cancer patients: The role
of perceived stigma. Psycho‐Oncology, 20 doi:10.1002/pon.1882

Greenfield, D. M., Walters, S. J., Coleman, R. E., Hancock, B. W., Snowden, J. A.,
Shalet, S. M., . . . Ross, R. J. M. (2010). Quality of life, self‐esteem, fatigue, and
sexual function in young men after cancer. Cancer, 116(6), 1592-1601.

Heimberg, R. G., Horner, K. J., Juster, H. R., Safren, S. A., Brown, E. J., & Schneier, F.
R. (1999). Psychometric properties of the liebowitz social anxiety scale.
Psychological Medicine, 29(1), 199-212.

Hilton, S., Emslie, C., Hunt, K., Chapple, A., & Ziebland, S. (2009). Disclosing a cancer
diagnosis to friends and family: A gendered analysis of young men's and women's
experiences. Qualitative Health Research, 19(6), 744-754.

Holland, J. C., Kelly, B. J., & Weinberger, M. I. (2010). Why psychosocial care is
difficult to integrate into routine cancer care: Stigma is the elephant in the room.
Journal of the National Comprehensive Cancer Network, 8(4), 362-366.

Ibbotson, T., Maguire, P., Selby, P., Priestman, T., & Wallace, L. (1994). Screening for
anxiety and depression in cancer patients: The effects of disease and treatment.
European Journal of Cancer, 30(1), 37-40.

64

Jacobsen, P. B., & Jim, H. S. (2008). Psychosocial interventions for anxiety and
depression in adult cancer patients. CA: A Cancer Journal for Clinicians, 58(4), 214230.

Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: A Cancer
Journal for Clinicians, 60(5), 277-300.

Lane, J. D., & Wegner, D. M. (1995). The cognitive consequences of secrecy. Journal of
Personality and Social Psychology, 69(2), 237-253.

Leary, M. R. (1996). The self-presentational motive. In M. R. Leary (Ed.), Selfpresentation: Impression management and interpersonal behavior (pp. 39-64).
Boulder, CO: Westview Press.

Liebowitz, M. R. (1987). Social anxiety. Modern Problems in Pharmacopsychiatry, 22,
141-173.

Lobchuk, M. M., Murdoch, T., McClement, S. E., & McPherson, C. (2008). A dyadic
affair: Who is to blame for causing and controlling the patient's lung cancer? Cancer
Nursing, 31(6), 435-443.

Major, B., & Gramzow, R. H. (1999). Abortion as stigma: Cognitive and emotional
implications of concealment. Journal of Personality and Social Psychology, 77(4),
735-745.

65

Maliski, S. L., Rivera, S., Connor, S., Lopez, G., & Litwin, M. S. (2008). Renegotiating
masculine identity after prostate cancer treatment. Qualitative Health Research,
18(12), 1609-1620.

Marlow, L. A. V., Waller, J., & Wardle, J. (2010). Variation in blame attributions across
different cancer types. Cancer Epidemiology Biomarkers & Prevention, 19(7), 1799.

Mitchell, P. H., Powell, L., Blumenthal, J., Norten, J., Ironson, G., Pitula, C. R., . . .
Berkman, L. F. (2003). A short social support measure for patients recovering from
myocardial infarction: The ENRICHD social support inventory. Journal of
Cardiopulmonary Rehabilitation, 23(6), 398-403.

Montgomery, G. H., Kangas, M., David, D., Hallquist, M. N., Green, S., Bovbjerg, D. H.,
& Schnur, J. B. (2009). Fatigue during breast cancer radiotherapy: An initial
randomized study of cognitive–behavioral therapy plus hypnosis. Health
Psychology, 28(3), 317-322.

Moos, R. H. (1993). Coping responses inventory. Odessa, FL: Psychological Assessment
Resources, Inc.

Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., &
Carbone, P. P. (1982). Toxicity and response criteria of the eastern cooperative
oncology group. American Journal of Clinical Oncology, 5(6), 649-655.

Pachankis, J. E. (2007). The psychological implications of concealing a stigma: A
cognitive-affective-behavioral model. Psychological Bulletin, 133(2), 328-345.

66

Petrak, J. A., Doyle, A. M., Smith, A., Skinner, C., & Hedge, B. (2001). Factors
associated with self‐disclosure of HIV serostatus to significant others. British
Journal of Health Psychology, 6(1), 69-79.

Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for
assessing and comparing indirect effects in multiple mediator models. Behavior
Research Methods, 40(3), 879-891.

Purdon, C. (1999). Thought suppression and psychopathology. Behaviour Research and
Therapy, 37(11), 1029-1054.

Rosenberg, M. (1979). Conceiving the self. New York: Basic Books.

Scheier, M. F., & Carver, C. S. (1985). The Self‐Consciousness scale: A revised version
for use with general populations. Journal of Applied Social Psychology, 15(8), 687699.

Schonfeld, N., & Timsit, J. F. (2008). Overcoming a stigma: The lung cancer patient in
the intensive care unit. European Respiratory Journal, 31(1), 3-5.

Seale, C., & Charteris-Black, J. (2008). The interaction of age and gender in illness
narratives. Ageing and Society, 28(07), 1025-1045.

Weiss, D. S., & Marmar, C. R. (1997). The impact of event scale - revised. In J. Wilson,
& T. M. Keane (Eds.), Assessing psychological trauma and PTSD (pp. 399-411).
New York: Guilford Press.

67

Wismeijer, A., & van Assen, M. (2008). Do neuroticism and extraversion explain the
negative association between self-concealment and subjective well-being?
Personality and Individual Differences, 45(5), 345-349.

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta
Psychiatrica Scandanavia, 67, 361-370.

68

Appendices

69

Appendix A: IRB Approval Letter

70

71

72

